You are viewing an incomplete version of our website. Please click to reload the website as full version.

Bcl2 Modifying Factor (BMF) (N-Term) Peptide

Details for Product No. ABIN1382119, Supplier: Login to see
Protein Name
  • BMF
  • AW260063
  • AW411872
Protein Region
N-Term
Origin
Human
3
Application
Blocking Peptide (BP)
Supplier
Login to see
Supplier Product No.
Login to see
Request

Showcase your results, aid the scientific community, and receive a full refund.

Contribute a validation

Learn more

Blocked Antibody anti-BMF antibody (Bcl2 Modifying Factor) (N-Term) (ABIN1031277)
Characteristics 13 amino amino terminus of human Bmf.
Human
Research Area Signaling, Cytoskeleton, Apoptosis/Necrosis, Cancer
Application Notes Bmf peptide is used for blocking the. activity of Bmf.
Restrictions For Research Use only
Format Liquid
Concentration 200 μg/mL
Buffer PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1 % bovine serum albumin and 0.02 % sodium azide
Preservative Sodium azide
Precaution of Use This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage -20 °C
Expiry Date 12 months
Background publications Heiser, Labi, Erlacher et al.: "The Bcl-2 protein family and its role in the development of neoplastic disease." in: Experimental gerontology, Vol. 39, Issue 8, pp. 1125-35, 2004 (PubMed).

Puthalakath, Villunger, OReilly et al.: "Bmf: a proapoptotic BH3-only protein regulated by interaction with the myosin V actin motor complex, activated by anoikis." in: Science (New York, N.Y.), Vol. 293, Issue 5536, pp. 1829-32, 2001 (PubMed).

Tan, Tan, Chan et al.: "MAP-1, a novel proapoptotic protein containing a BH3-like motif that associates with Bax through its Bcl-2 homology domains." in: The Journal of biological chemistry, Vol. 276, Issue 4, pp. 2802-7, 2001 (PubMed).